TELO
Telomir Pharmaceuticals, Inc.
1.20$
-0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | 0.13 | – | – | |
| – | – | -0.13 | – | – | |
| 0.00 | 0.03 | 0.05 | 0.08 | 0.08 | |
| 0.00 | 0.00 | 0.02 | 0.33 | 0.26 | |
| 0.00 | 0.03 | 0.13 | 0.41 | 0.33 | |
| 0.00 | -0.03 | -0.13 | -0.41 | -0.33 | |
| – | 0.00 | 0.06 | 0.15 | 0.00 | |
| 0.00 | -0.03 | -0.44 | -0.56 | -0.33 | |
| 0.00 | -0.03 | -0.08 | -0.56 | – | |
| 0.00 | -0.03 | -0.44 | -0.56 | -0.33 | |
| 0.00 | -0.03 | -0.39 | 0.00 | -0.33 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.